Results 161 to 170 of about 5,389 (188)

Cirrhotic Cardiomyopathy: A New Clinical Phenotype

Arquivos Brasileiros de Cardiologia
Luis Otávio Cardoso Mocarzel, Mariana Macedo Rossi, Bruna de Mello Miliosse, Pedro Gemal Lanzieri, Ronaldo Altenburg Gismondi   +4 more
doaj   +1 more source

[Cirrhotic cardiomyopathy – Clinically fact or academic curiosity? Review. Part 3: treatment] [PDF]

Rev Fac Cien Med Univ Nac Cordoba
Ramos H, Altieri M.
europepmc   +1 more source

Protective role of cardiac-specific overexpression of caveolin-3 in cirrhotic cardiomyopathy.

Am J Physiol Gastrointest Liver Physiol, 2020
Kim SY, Kim KH, Schilling JM, Leem J, Dhanani M, Head BP, Roth DM, Zemljic-Harpf AE, Patel HH.   +8 more
europepmc   +1 more source

[Cirrhotic cardiomyopathy – Clinically fact or academic curiosity? Review: Part 1: definition, epidemiology, pathology and clinical manifestations] [PDF]

Rev Fac Cien Med Univ Nac Cordoba
Ramos H, Altieri M.
europepmc   +1 more source

[Cirrhotic cardiomyopathy – Clinically fact or academic curiosity? Review. Part 2: ECG, functional tests, images, biomarkers, screening for coronary heart disease and differentianting diagnosis] [PDF]

Rev Fac Cien Med Univ Nac Cordoba
Ramos H, Altieri M.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

An update on cirrhotic cardiomyopathy

Expert Review of Gastroenterology & Hepatology, 2019
Cirrhosis with portal hypertension and related complications are associated with a high mortality. Excess of circulating vasodilators and cardiodepressive substances lead to a hyperdynamic circulation with changed myocardial structure and function. The entity cirrhotic cardiomyopathy seems to be involved in different aspects of hepatic decompensation ...
Møller, Søren, Danielsen, Karen V, Wiese, Signe, Hove, Jens D, Bendtsen, Flemming   +4 more
openaire   +5 more sources

Advances in cirrhotic cardiomyopathy

Current Opinion in Gastroenterology, 2021
Purpose of review Cirrhotic cardiomyopathy (CCM) is a well-recognized entity. When patients with CCM encounter challenges such as liver transplantation, overt cardiac dysfunction manifests, leading to morbidity and mortality.
Hongqun, Liu, Ki Tae, Yoon, Jing, Zhang, Samuel S, Lee   +3 more
openaire   +2 more sources

Cirrhotic Cardiomyopathy—A Veiled Threat

Cardiology in Review, 2020
Cirrhotic cardiomyopathy (CCM) is defined as cardiac dysfunction in patients with liver cirrhosis without preexisting cardiac disease. According to the definition established by the World Congress of Gasteroenterology in 2005, the diagnosis of CCM includes criteria reflecting systolic dysfunction, impaired diastolic relaxation, and electrophysiological
Ecaterina, Scarlatescu, Sergey P, Marchenko, Dana R, Tomescu   +2 more
openaire   +2 more sources

Therapy Insight: cirrhotic cardiomyopathy

Nature Clinical Practice Gastroenterology & Hepatology, 2006
Liver cirrhosis is associated with several cardiovascular disturbances. These disturbances include hyperdynamic systemic circulation, manifested by an increased cardiac output and decreased peripheral vascular resistance and arterial pressure. Despite the baseline increase in cardiac output, cardiac function in patients with cirrhosis is abnormal in ...
Seyed A, Gaskari, Hooman, Honar, Samuel S, Lee   +2 more
openaire   +2 more sources

Cirrhotic cardiomyopathy: Indian scenario

Journal of Gastroenterology and Hepatology, 2007
AbstractBackground:  Cirrhotic cardiomyopathy has been reported to be a major cause of morbidity and mortality in liver transplant recipients. However, there is scant data from Asia. With liver transplantation programs gradually being established in the region, Asian hepatologists are bound to face this entity.Methods:  Thirty patients with alcoholic ...
Jacob, Alexander, Peeyush, Mishra, Nutan, Desai, Shekhar, Ambadekar, Bharat, Gala, Prabha, Sawant   +5 more
openaire   +2 more sources